Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

616 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The role of mTOR in the management of solid tumors: an overview.
Strimpakos AS, Karapanagiotou EM, Saif MW, Syrigos KN. Strimpakos AS, et al. Among authors: saif mw. Cancer Treat Rev. 2009 Apr;35(2):148-59. doi: 10.1016/j.ctrv.2008.09.006. Epub 2008 Nov 14. Cancer Treat Rev. 2009. PMID: 19013721 Review.
Targeted therapy for oesophageal cancer: an overview.
Syrigos KN, Zalonis A, Kotteas E, Saif MW. Syrigos KN, et al. Among authors: saif mw. Cancer Metastasis Rev. 2008 Jun;27(2):273-88. doi: 10.1007/s10555-008-9117-z. Cancer Metastasis Rev. 2008. PMID: 18224295 Review.
Pancreatic cancer: translating lessons from mouse models.
Strimpakos AS, Hoimes C, Saif MW. Strimpakos AS, et al. Among authors: saif mw. JOP. 2009 Mar 9;10(2):98-103. JOP. 2009. PMID: 19287100
Novel therapeutic approaches and mechanisms in neuroendocrine tumors: the role of targeted agents.
Papaxoinis G, Syrigos K, Saif MW. Papaxoinis G, et al. Among authors: saif mw. Discov Med. 2016 May;21(117):391-402. Discov Med. 2016. PMID: 27355335
A phase 1, dose-escalation, pharmacokinetic and pharmacodynamic study of BIIB021 administered orally in patients with advanced solid tumors.
Saif MW, Takimoto C, Mita M, Banerji U, Lamanna N, Castro J, O'Brien S, Stogard C, Von Hoff D. Saif MW, et al. Clin Cancer Res. 2014 Jan 15;20(2):445-55. doi: 10.1158/1078-0432.CCR-13-1257. Epub 2013 Oct 4. Clin Cancer Res. 2014. PMID: 24097863 Clinical Trial.
Pancreatic cancer: from molecular pathogenesis to targeted therapy.
Strimpakos A, Saif MW, Syrigos KN. Strimpakos A, et al. Among authors: saif mw. Cancer Metastasis Rev. 2008 Sep;27(3):495-522. doi: 10.1007/s10555-008-9134-y. Cancer Metastasis Rev. 2008. PMID: 18427734 Review.
Pancreatic neuroendocrine tumors: targeting the molecular basis of disease.
Khagi S, Saif MW. Khagi S, et al. Among authors: saif mw. Curr Opin Oncol. 2015 Jan;27(1):38-43. doi: 10.1097/CCO.0000000000000146. Curr Opin Oncol. 2015. PMID: 25390554 Review.
New concepts in the treatment strategy of neuroendocrine tumors: the role of biotherapy.
Papaxoinis G, Syrigos K, Saif MW. Papaxoinis G, et al. Among authors: saif mw. Discov Med. 2016 May;21(117):381-9. Discov Med. 2016. PMID: 27355334 Review.
Triphendiol (NV-196), development of a novel therapy for pancreatic cancer.
Wang X, McKernan R, Kim KH, Alvero AB, Whiting A, Thompson JA, Mor G, Saif MW, Husband AJ, Brown DM, Tytler EM. Wang X, et al. Among authors: saif mw. Anticancer Drugs. 2011 Sep;22(8):719-31. doi: 10.1097/CAD.0b013e328346f3b4. Anticancer Drugs. 2011. PMID: 21666438
Capecitabine: an overview of the side effects and their management.
Saif MW, Katirtzoglou NA, Syrigos KN. Saif MW, et al. Anticancer Drugs. 2008 Jun;19(5):447-64. doi: 10.1097/CAD.0b013e3282f945aa. Anticancer Drugs. 2008. PMID: 18418212 Review.
616 results
Jump to page
Feedback